Mingchen HealthLtd 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jianming Chen

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	3.4yrs
CEO 소유권	n/a
경영진 평균 재임 기간	9.6yrs
이사회 평균 재임 기간	3.5yrs

최근 관리 업데이트

Recent updates

Mingchen Health Co.,Ltd.'s (SZSE:002919) Shares Climb 35% But Its Business Is Yet to Catch Up

Aug 15

We Like These Underlying Return On Capital Trends At Mingchen HealthLtd (SZSE:002919)

Aug 07

Mingchen Health Co.,Ltd. (SZSE:002919) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Jun 06

Solid Earnings Reflect Mingchen HealthLtd's (SZSE:002919) Strength As A Business

May 05

Mingchen Health Co.,Ltd. (SZSE:002919) Might Not Be As Mispriced As It Looks

Apr 17

Mingchen HealthLtd's (SZSE:002919) Returns On Capital Are Heading Higher

Feb 27

CEO

Jianming Chen (34 yo)

3.4yrs

테뉴어

CN¥525,100

보상

Mr. Jianming Chen serves as Director at Mingchen Health Co.,Ltd. since May 28, 2021 and serves its Chairman and General Manager since June 8, 2021.

리더십 팀

이름	위치	테뉴어	보상	소유권
Jianming Chen	Chairman & GM	3.4yrs	CN¥525.10k	데이터 없음
Peng Xiaoqing	Vice Chairman	9.6yrs	CN¥525.10k	0.59% CN¥ 24.4m
Dong Song Chen	Secretary of the Board	9.6yrs	CN¥525.10k	0.48% CN¥ 19.9m
Yaolin Lin	Accounting Supervisor	no data	데이터 없음	데이터 없음

9.6yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: 002919 의 관리팀은 노련하고 경험 (평균 재직 기간 9.6 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Jianming Chen	Chairman & GM	3.5yrs	CN¥525.10k	데이터 없음
Peng Xiaoqing	Vice Chairman	9.6yrs	CN¥525.10k	0.59% CN¥ 24.4m
Dong Song Chen	Secretary of the Board	3.5yrs	CN¥525.10k	0.48% CN¥ 19.9m
Jianhui Yu	Supervisor	9.6yrs	데이터 없음	데이터 없음
Hui Gao	Independent Director	3.5yrs	CN¥100.00k	데이터 없음
Shuibao Zhu	Independent Director	3.5yrs	CN¥100.00k	데이터 없음
Xiaoyan Wu	Independent Director	3.5yrs	CN¥100.00k	데이터 없음
Shaobo Du	Chairman of the Supervisory Board	6.5yrs	데이터 없음	데이터 없음
Fengling Cui	Supervisor	4.8yrs	데이터 없음	데이터 없음
Huanchao Xu	Director	2yrs	CN¥40.00k	데이터 없음

3.5yrs

평균 재임 기간

47yo

평균 연령

경험이 풍부한 이사회: 002919 의 이사회는 경험(평균 재직 기간 3.5 년)으로 간주됩니다.

Mingchen HealthLtd 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Mingchen Health Co.,Ltd., Annual General Meeting, May 20, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.25 in 3Q 2023)

Now 25% overvalued after recent price rise

Mingchen Health Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Second quarter 2024 earnings released: EPS: CN¥0.061 (vs CN¥0.25 in 2Q 2023)

Mingchen Health Co.,Ltd.'s (SZSE:002919) Shares Climb 35% But Its Business Is Yet to Catch Up

New minor risk - Share price stability

We Like These Underlying Return On Capital Trends At Mingchen HealthLtd (SZSE:002919)

Investor sentiment improves as stock rises 25%

Mingchen Health Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Mingchen Health Co.,Ltd. (SZSE:002919) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Mingchen Health Co.,Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 31 May 2024

Investor sentiment deteriorates as stock falls 21%

Mingchen Health Co.,Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 31 May 2024

Solid Earnings Reflect Mingchen HealthLtd's (SZSE:002919) Strength As A Business

Mingchen Health Co.,Ltd., Annual General Meeting, May 20, 2024

First quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.15 in 1Q 2023)

Mingchen Health Co.,Ltd. (SZSE:002919) Might Not Be As Mispriced As It Looks

Mingchen Health Co.,Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Investor sentiment improves as stock rises 16%

Mingchen HealthLtd's (SZSE:002919) Returns On Capital Are Heading Higher

New major risk - Share price stability

Mingchen Health Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024

Investor sentiment deteriorates as stock falls 19%

Investor sentiment improves as stock rises 15%

Third quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.22 loss in 3Q 2022)

Mingchen Health Co.,Ltd. to Report Q3, 2023 Results on Oct 30, 2023

Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.18 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.007 in 1Q 2022)

High number of new and inexperienced directors

Third quarter 2022 earnings released: CN¥0.28 loss per share (vs CN¥0.13 profit in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.23 (vs CN¥0.21 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Mingchen Health Co.,Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on June 6, 2022

Mingchen Health Co.,Ltd. Approves Cash Dividend for the Year 2021

Mingchen Health Co.,Ltd. (SZSE:002919) announces an Equity Buyback for CNY 100 million worth of its shares.

First quarter 2022 earnings released: EPS: CN¥0.01 (vs CN¥0.51 in 1Q 2021)

Mingchen Health Co.,Ltd. Proposes Final Cash Dividend for the Year 2021

High number of new and inexperienced directors

Third quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.25 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.30 (vs CN¥0.079 in 2Q 2020)

Mingchen Health Co.,Ltd. Announces Cash Dividend

Full year 2020 earnings released: EPS CN¥0.87 (vs CN¥0.19 in FY 2019)

New 90-day high: CN¥47.19

New 90-day low: CN¥37.00

New 90-day high: CN¥58.66

Third quarter earnings released

Mingchen Health Co.,Ltd. to Report Q3, 2020 Results on Oct 26, 2020

New 90-day high: CN¥52.21

New 90-day high: CN¥47.75

Mingchen Health Co.,Ltd. (SZSE:002919) entered into an equity transfer agreement to acquire Hainan Huaduo Network Technology Co., Ltd. from Xu Hongjian for approximately CNY 130 million.

First half earnings released

New 90-day high - CN¥40.37

Mingchen Health Co.,Ltd. to Report First Half, 2020 Results on Aug 31, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령